Antibodies, Neutralizing

DBCAT005596Pharmacologic class

Antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent, usually a virus. A DrugBank category of 9 drugs. 2 of them are approved.

Drugs: Actoxumab
AVP-21D9
Bentracimab
Bezlotoxumab
Carlumab
Dusigitumab
Fletikumab
Patritumab
Suvratoxumab

What you can answer from here — as of January 13, 2022

9DrugsEach linked to its full drug card

Listed above

8Drug targetsEvery drug–target pair in the class, with bond type

5Marketed productsAcross the regions we cover, with dosage forms and routes

2Routes of administrationHow the drugs in this class are given

Which targets do Antibodies, Neutralizing share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account